"This protection would be long-term," said Jia Xie, senior staff scientist at The Scripps Research Institute (TSRI) in the US and first author of the study published in the journal Proceedings of the National Academy of Sciences.
The researchers found a way to tether HIV-fighting antibodies to immune cells, thereby creating a cell population resistant to the virus.
Their experiments under lab conditions showed that these resistant cells can replace diseased cells.
The new technique offers a significant advantage over therapies where antibodies float freely in the bloodstream at a relatively low concentration, the researchers said.
Instead, antibodies in the new study hang on to a cell's surface, blocking HIV from accessing a crucial cell receptor and spreading infection.
The researchers said they plan to collaborate with investigators at City of Hope -- an independent research and treatment centre for cancer, diabetes and other life-threatening diseases in the US -- to evaluate this new therapy in efficacy and safety tests, as required by federal regulations, prior to testing in patients.
(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)
Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.
This website uses cookies.